Anyone interested in Pacific Biosciences of California, Inc. (NASDAQ:PACB) should probably be aware that the Chief Operating Officer, Mark Van Oene, recently divested US$241k worth of shares in the company, at an average price of US$7.77 each. The eyebrow raising move amounted to a reduction of 12% in their holding.
See our latest analysis for Pacific Biosciences of California
Pacific Biosciences of California Insider Transactions Over The Last Year
In the last twelve months, the biggest single sale by an insider was when the President, Christian O. Henry, sold US$980k worth of shares at a price of US$10.12 per share. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. The good news is that this large sale was at well above current price of US$6.71. So it is hard to draw any strong conclusion from it.
Insiders in Pacific Biosciences of California didn't buy any shares in the last year. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!
If you are like me, then you will not want to miss this free list of growing companies that insiders are buying.
Insider Ownership Of Pacific Biosciences of California
Many investors like to check how much of a company is owned by insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. From our data, it seems that Pacific Biosciences of California insiders own 0.3% of the company, worth about US$5.5m. We do generally prefer see higher levels of insider ownership.
So What Does This Data Suggest About Pacific Biosciences of California Insiders?
An insider sold Pacific Biosciences of California shares recently, but they didn't buy any. And there weren't any purchases to give us comfort, over the last year. When you consider that most companies have higher levels of insider ownership, we're a little wary. So we'd only buy after very careful consideration. While we like knowing what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. Every company has risks, and we've spotted 4 warning signs for Pacific Biosciences of California you should know about.
Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.